Page last updated: 2024-10-22

amifostine anhydrous and Pyrexia

amifostine anhydrous has been researched along with Pyrexia in 3 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koukourakis, MI1
Pitsiava, D1
Giatromanolaki, A1
Kambouromiti, G1
Sivridis, E1
Kartalis, G1
Boehme, S1
Wilson, DB1
Shaw, PJ1
Bleakley, M1

Reviews

1 review available for amifostine anhydrous and Pyrexia

ArticleYear
Amifostine-induced fever: case report and review of the literature.
    Pharmacotherapy, 2004, Volume: 24, Issue:1

    Topics: Amifostine; Carcinoma, Squamous Cell; Combined Modality Therapy; Fever; Head and Neck Neoplasms; Hum

2004

Other Studies

2 other studies available for amifostine anhydrous and Pyrexia

ArticleYear
Amifostine-related fever-rash during fractionated radiotherapy: diagnostic and predictive role of C-reactive protein.
    American journal of clinical oncology, 2011, Volume: 34, Issue:3

    Topics: Adult; Aged; Amifostine; Biomarkers; C-Reactive Protein; Dose Fractionation, Radiation; Drug Adminis

2011
Systemic inflammatory response syndrome associated with amifostine.
    Medical and pediatric oncology, 2000, Volume: 34, Issue:4

    Topics: Amifostine; Antineoplastic Agents; Brain Stem Neoplasms; Child, Preschool; Drug Eruptions; Edema; Er

2000